JP2017528715A - 細胞齢を決定するシステムと方法 - Google Patents

細胞齢を決定するシステムと方法 Download PDF

Info

Publication number
JP2017528715A
JP2017528715A JP2017513624A JP2017513624A JP2017528715A JP 2017528715 A JP2017528715 A JP 2017528715A JP 2017513624 A JP2017513624 A JP 2017513624A JP 2017513624 A JP2017513624 A JP 2017513624A JP 2017528715 A JP2017528715 A JP 2017528715A
Authority
JP
Japan
Prior art keywords
hba1c
fraction
cells
average
age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2017513624A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017528715A5 (https=
Inventor
アグトーヴェン アンドレー ヴァン，
アグトーヴェン アンドレー ヴァン，
ファブリス マレーグ，
ファブリス マレーグ，
クリストフ ゴデフロイ，
クリストフ ゴデフロイ，
エンリケ ラベリノ，
エンリケ ラベリノ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckman Coulter Inc
Original Assignee
Beckman Coulter Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Coulter Inc filed Critical Beckman Coulter Inc
Publication of JP2017528715A publication Critical patent/JP2017528715A/ja
Publication of JP2017528715A5 publication Critical patent/JP2017528715A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/492—Determining multiple analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/726—Devices
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/012—Red blood cells
    • G01N2015/014—Reticulocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1402—Data analysis by thresholding or gating operations performed on the acquired signals or stored data
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1477—Multiparameters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1488—Methods for deciding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
JP2017513624A 2014-09-12 2015-09-11 細胞齢を決定するシステムと方法 Ceased JP2017528715A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462049970P 2014-09-12 2014-09-12
US62/049,970 2014-09-12
US201462059684P 2014-10-03 2014-10-03
US62/059,684 2014-10-03
PCT/US2015/049797 WO2016040870A1 (en) 2014-09-12 2015-09-11 Systems and methods to determine the age of cells

Publications (2)

Publication Number Publication Date
JP2017528715A true JP2017528715A (ja) 2017-09-28
JP2017528715A5 JP2017528715A5 (https=) 2018-09-27

Family

ID=54238558

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017513624A Ceased JP2017528715A (ja) 2014-09-12 2015-09-11 細胞齢を決定するシステムと方法

Country Status (5)

Country Link
US (1) US10739357B2 (https=)
EP (1) EP3191848A1 (https=)
JP (1) JP2017528715A (https=)
CN (1) CN106716138B (https=)
WO (1) WO2016040870A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023073397A (ja) * 2018-10-26 2023-05-25 アボット ダイアベティス ケア インコーポレイテッド 生理学的パラメータ分析のための方法、デバイスおよびシステム

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3013360B1 (fr) * 2013-11-19 2015-12-04 Snecma Procede integre de frittage pour microfissuration et tenue a l'erosion des barrieres thermiques
EP3602003B1 (en) * 2017-03-31 2026-04-22 Life Technologies Corporation Apparatuses, systems and methods for imaging flow cytometry
CN115004310A (zh) 2019-11-25 2022-09-02 雅培糖尿病护理公司 用于生理参数分析的方法、设备和系统
JP2021103139A (ja) * 2019-12-25 2021-07-15 ソニーグループ株式会社 情報処理装置、粒子測定装置、粒子測定システム、粒子分取装置、粒子分取システム、情報処理方法、及び情報処理プログラム
CN112305207B (zh) * 2020-10-20 2023-03-10 上海交通大学 基于HbA1c和血糖浓度为传感变量的红细胞平均寿命检测方法
WO2024094854A1 (en) * 2022-11-03 2024-05-10 Institut National de la Santé et de la Recherche Médicale Method for determining the relative age of red blood cells
WO2025210140A1 (en) * 2024-04-04 2025-10-09 Institut National de la Santé et de la Recherche Médicale Method for determining the age of red blood cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099301A1 (en) * 2005-10-28 2007-05-03 Tyvoll David A Systems and methods for measuring glycated hemoglobin
JP2010500570A (ja) * 2006-08-09 2010-01-07 ベックマン コールター，インコーポレイティド 細胞ヘモグロビンの測定方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69212999T2 (de) 1991-04-08 1997-03-27 Chronomed Inc Verfahren zur Analyse der Glykierung von Hämoglobin
US7534618B2 (en) * 2005-10-28 2009-05-19 Hewlett-Packard Development Company, L.P. Systems and methods for measuring glycated hemoglobin
US7968279B2 (en) 2008-08-13 2011-06-28 Beckman Coulter, Inc. Reference control for cell by cell analysis
EP2433140B1 (en) 2009-05-20 2015-02-11 Relia Diagnostic Systems, Inc. Systems and methods for determining the percentage of glycated hemoglobin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099301A1 (en) * 2005-10-28 2007-05-03 Tyvoll David A Systems and methods for measuring glycated hemoglobin
JP2010500570A (ja) * 2006-08-09 2010-01-07 ベックマン コールター，インコーポレイティド 細胞ヘモグロビンの測定方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023073397A (ja) * 2018-10-26 2023-05-25 アボット ダイアベティス ケア インコーポレイテッド 生理学的パラメータ分析のための方法、デバイスおよびシステム
JP7463590B2 (ja) 2018-10-26 2024-04-08 アボット ダイアベティス ケア インコーポレイテッド 生理学的パラメータ分析のための方法、デバイスおよびシステム
JP2024079874A (ja) * 2018-10-26 2024-06-12 アボット ダイアベティス ケア インコーポレイテッド 生理学的パラメータ分析のための方法、デバイスおよびシステム

Also Published As

Publication number Publication date
WO2016040870A9 (en) 2017-04-06
US20180231573A1 (en) 2018-08-16
US10739357B2 (en) 2020-08-11
EP3191848A1 (en) 2017-07-19
WO2016040870A1 (en) 2016-03-17
CN106716138B (zh) 2019-06-14
CN106716138A (zh) 2017-05-24

Similar Documents

Publication Publication Date Title
JP2017528715A (ja) 細胞齢を決定するシステムと方法
Masucci et al. Validation of biomarkers to predict response to immunotherapy in cancer: volume I—pre-analytical and analytical validation
MacFarlane IV et al. NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors
Huang et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
US7022834B2 (en) Isotopically labelled DNA
Dejoie et al. Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma
Roshal et al. Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection
Ladell et al. Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression
Spiliotaki et al. Dynamic monitoring of PD‐L1 and Ki67 in circulating tumor cells of metastatic non‐small cell lung cancer patients treated with pembrolizumab
Sarikonda et al. Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses
US20250020636A1 (en) Predicting Responses to Immunotherapy
Hoffmann et al. Reference intervals of extended erythrocyte and reticulocyte parameters
Illingworth et al. Sensitive and accurate identification of PNH clones based on ICCS/ESCCA PNH Consensus Guidelines—A summary
US20210125684A1 (en) Systems and methods for quantitatively predicting response to immune-based therapy in cancer patients
Cesano et al. Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readouts
Mfarrej et al. Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products
Hermansen et al. A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine
Keel Quality control, quality assurance, and proficiency testing in the andrology laboratory
Steussy et al. Algorithms utilizing peripheral blood hematopoietic progenitor cell counts in lieu of some CD 34+ cell counts predict successful peripheral blood stem cell collections with substantial time and cost savings
Dyhdalo et al. Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation procedures
Crawford et al. Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection
Ramos et al. High-Dimensional Phospho-CyTOF Characterization of T-Cell Activation Responses in Whole Blood
US20200209222A1 (en) Flow based assays for therapeutics
Shai et al. A multicenter study evaluating the flowcytometric-based kit for semen analysis
Salem et al. Clinical implementation of a one-step no-wash flow cytometry method allows for real-time monitoring of patients treated with autologous CAR-T cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180815

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180815

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190627

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190805

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200508

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200807

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200825

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210203

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20210628